Home › Products › Orthopaedics › Idromet 6mg Injection
Idromet 6mg Injection
Salt Composition: IBANDRONIC ACID
- Manufacturer: AUREATE HEALTHCARE PVT LTD
- Pack Size: 1 VIAL(s) OF 6ML
- Dosage Form: INJECTION
- Strength: 6MG
- Prescription Required
- Storage: Keep Idromet 6mg Injection out of sight and reach of children. Eating a balanced food rich in calcium and vitamin D will help you get the most benefit from the treatment.
₹1574.00₹2578.13
Inclusive of all taxes
Product Introduction
Idromet 6mg Injection belongs to a class of medicines called bisphosphonates. It contains Ibandronic acid as the active constituent. It is predominantly used in treating osteoporosis, especially in postmenopausal women. Osteoporosis occurs commonly in women at postmenopause due to depletion of the oestrogen hormone. This medicine may reverse bone loss and help reduce the chance of fractures. Do not take this medicine if you are allergic to Ibandronic acid or other ingredients. Talk to your doctor if you have difficulty sitting or standing upright for at least one hour at a time or if you have a history of low blood calcium levels. Before starting treatment with Idromet 6mg, inform your doctor if you have any mouth or teeth problems such as gum disease, poor dental health, planned tooth extraction, or have not had routine dental care for a long time. Report to your doctor if you are a smoker; this may increase the risk of dental problems. Notify your doctor if you have any history of cancer or prior treatment with Bisphosphonates (used to treat or prevent bone disorders) or are taking Corticosteroids (Prednisolone or Dexamethasone). Inform your doctor if you have any problems with the oesophagus, stomach problems, kidney disorders, or are planning to have dental surgery. This injection contains lactose. Be sure to discuss with your doctor if you are intolerant to sugars.
Uses
Prevent the risk of fractures Osteoporosis in postmenopausal women
How it works
Idromet 6mg Injection belongs to the class of bisphosphonates. It produces its action by acting on the soft bone tissue, which inhibits bone resorption by blocking the activity of osteoclasts and indirectly works to increase bone density.
How to Use
Idromet 6mg Injection is indicated for intravenous use only. To ensure the dosage as directed by the physician, This medicine should be administered by a well-trained medical staff or doctor with experience working in treating cancer patients. Ibandronic is usually given as an infusion into veins for about 2 hours to treat rumor-induced hypercalcemia. If this medicine is prescribed, your physician will choose the dosage based on your medical condition because it differs for each person.
Side Effects
.Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them. Common Fever with chills Heartburn Muscle cramps Headache Flu-like symptoms with a body ache Stomach pain with diarrhea Swollen legs Bone and joint pain Dental problems
Expert Tips
Inform your physician before receiving an Idromet 6mg Injection if you have any of the medical issues or had an allergic history to Ibandronic acid or any other Bisphosphonate or a history of the bone disorder. This medicine is to be used cautiously in patients with kidney diseases or impairment. However, your physician may adjust the dose and the infusion duration according to your creatinine clearance if you have kidney problems. Please discuss your physician before taking this medicine. Inform your doctor if you are lactose tolerance because this medicine contains lactose sugar.
References
- Accord healthcare, Patient information leaflet, [Revised on March 2022];[Accessed on 20th May 2022]; https://www.medicines.org.uk/emc/files/pil.1244.pdf
- M Dooley et al; Ibandronate; [Published 2012]; [Accessed 1/04/2021]; https://pubmed.ncbi.nlm.nih.gov/9951955/
- Ibandronic acid; Cancer Research United kingdom; [Published on September 2020]; [Accessed on 20th May 2022]; https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/ibandronic-acid
- Inderjeeth CA, Glendenning P, Ratnagobal S, Inderjeeth DC, Ondhia C. Long-term efficacy, safety, and patient acceptability of ibandronate in treating postmenopausal osteoporosis. International Journal of Women's Health. 2015;7:7. [Published on 2015]; [Accessed on 20th May 2022]; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274146/
Safety Advice
Pregnancy: unsafe Consult your doctor before receiving Idromet 6mg Injection. This medicine is unsafe and is not recommended if you are pregnant or planning to get pregnant.
Lungs: Consult your doctor Consult your doctor if you experience any lung-related symptoms.
Breastfeeding: unsafe It is unsafe, and it is advised to avoid Idromet 6mg Injection if you are in a breastfeeding period.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.